Literature DB >> 12745251

A SWI/SNF-like factor from chicken liver that disrupts nucleosomes and transfers histone octamers in cis and trans.

Anil K Panigrahi1, Raghuvir S Tomar, Madan M Chaturvedi.   

Abstract

ATP-dependent chromatin remodeling factors have been implicated in nuclear processes involving DNA. Here we report partial purification and characterization of an ATP-dependent chromatin remodeling activity from chicken liver. Nuclear extract from chicken liver was fractionated chromatographically to enrich proteins immunoreacting to antibodies against components of human SWI/SNF, namely BRG1, BAF170, BAF155, and BAF57. Immunoreactivity to these antibodies elutes with a mass of about 2MDa on Sepharose CL-6B gel filtration, suggesting that they constitute a SWI/SNF-like complex (SLC). The SLC displays three chromatin-remodeling activities, viz. nucleosome disruption, octamer transfer, and nucleosome sliding (octamer transfer in cis). We further show that components of SLC, as revealed by immunoreactivity to the above antibodies, display a dynamic nucleocytoplasmic distribution and colocalize with RNA polymerase II in the liver nuclei. This report contributes to the understanding of phylogenetic generality of chromatin remodeling factors in eukaryotes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12745251     DOI: 10.1016/s0003-9861(03)00175-9

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  2 in total

1.  Histone octamer trans-transfer: a signature mechanism of ATP-dependent chromatin remodelling unravelled in wheat nuclear extract.

Authors:  Vishal V Raut; Shashibhal M Pandey; Jayashree K Sainis
Journal:  Ann Bot       Date:  2011-09-06       Impact factor: 4.357

2.  Brg1-mediated Nrf2/HO-1 pathway activation alleviates hepatic ischemia-reperfusion injury.

Authors:  Mian Ge; Weifeng Yao; Dongdong Yuan; Shaoli Zhou; Xi Chen; Yihan Zhang; Haobo Li; Zhengyuan Xia; Ziqing Hei
Journal:  Cell Death Dis       Date:  2017-06-01       Impact factor: 8.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.